Related Experiment Video
Updated: Jun 20, 2026

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
[Anti-PR3 positive inflammatory bowel disease. Description of a case]
Caterina Defendenti1, Simona Bollani, Maria Francesca Spina
1Laboratorio Analisi, Ospedale Fatebenefratelli, Milano. caterina.defendenti@fbf.milano.it
Abstract:
We descrive the case of a patient with inflammatory bowel disease complicated by erythema nodosum and anti PR3 positivity. The patient was exposed to two different bacteria: salmonellosis was reported in patient history, while Staphylococcus aureus infection was diagnosed during the present hospital stay. Antibiotics and steroids are effective.
Insights
This case study highlights a patient with inflammatory bowel disease experiencing erythema nodosum and anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA). Bacterial infections, including Salmonella and Staphylococcus aureus, were noted, and treatment with antibiotics and steroids proved effective.
Area of Science:
- Gastroenterology
- Rheumatology
- Infectious Diseases
Background:
- Inflammatory bowel disease (IBD) encompasses chronic gastrointestinal inflammation.
- Erythema nodosum is a common extraintestinal manifestation of IBD.
- Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, particularly anti-PR3 positivity, can occur in IBD patients.
Observation:
- A case of IBD is presented with concurrent erythema nodosum.
- The patient exhibited positivity for anti-PR3 antibodies.
- The patient had a history of salmonellosis and a current Staphylococcus aureus infection.
Findings:
- The co-occurrence of IBD, erythema nodosum, and anti-PR3 positivity suggests a complex interplay of immune dysregulation.
- Bacterial infections may act as potential triggers or complicating factors in this clinical scenario.
- Treatment with antibiotics and corticosteroids demonstrated efficacy in managing the patient's condition.
Implications:
- This case underscores the importance of considering ANCA-associated vasculitis in IBD patients presenting with erythema nodosum.
- Identifying and treating bacterial infections may be crucial for managing complex IBD cases.
- The findings suggest a potential therapeutic role for antibiotics and steroids in such complicated presentations.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

